Click here to get full coverage on T cell therapy company Autolus schedules Mar. 27 results call - Stock Titan

T cell therapy company Autolus schedules Mar. 27 results call  Stock Titan

T cell therapy company Autolus schedules Mar. 27 results call - Stock Titan

Click here to get full coverage on Autolus Therapeutics to Announce Q4 and Full Year 2025 Financial Results on March 27, 2026 - Quiver Quantitative

Autolus Therapeutics to Announce Q4 and Full Year 2025 Financial Results on March 27, 2026  Quiver Quantitative

Autolus Therapeutics to Announce Q4 and Full Year 2025 Financial Results on March 27, 2026 - Quiver Quantitative

Click here to get full coverage on Autolus Therapeutics (AUTL) Valuation Check After Revenue Guidance And AUCATZYL UK And EU Approvals - Yahoo Finance

Autolus Therapeutics (AUTL) Valuation Check After Revenue Guidance And AUCATZYL UK And EU Approvals  Yahoo Finance

Autolus Therapeutics (AUTL) Valuation Check After Revenue Guidance And AUCATZYL UK And EU Approvals - Yahoo Finance

Click here to get full coverage on Autolus Therapeutics (AUTL) Is Down 25.0% After Raising 2026 Revenue Guidance And Advancing Obe-cel Trials - simplywall.st

Autolus Therapeutics (AUTL) Is Down 25.0% After Raising 2026 Revenue Guidance And Advancing Obe-cel Trials  simplywall.st

Autolus Therapeutics (AUTL) Is Down 25.0% After Raising 2026 Revenue Guidance And Advancing Obe-cel Trials - simplywall.st

Click here to get full coverage on AUTL Stock Soars Pre-market On Positive Recommendation For Cell Therapy Targeting Cancer In UK - Stocktwits

AUTL Stock Soars Pre-market On Positive Recommendation For Cell Therapy Targeting Cancer In UK  Stocktwits

AUTL Stock Soars Pre-market On Positive Recommendation For Cell Therapy Targeting Cancer In UK - Stocktwits

Click here to get full coverage on AUTL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

AUTL Financials: Income Statement, Balance Sheet & Cash Flow  Stock Titan

AUTL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Click here to get full coverage on Is Autolus Therapeutics plc (AUTL) The Best Get Rich Fast Stocks to Buy Right Now? - Yahoo Finance

Is Autolus Therapeutics plc (AUTL) The Best Get Rich Fast Stocks to Buy Right Now?  Yahoo Finance

Is Autolus Therapeutics plc (AUTL) The Best Get Rich Fast Stocks to Buy Right Now? - Yahoo Finance

Click here to get full coverage on A Fresh Look at Autolus Therapeutics (AUTL) Valuation Following Earnings, Obe-cel Expansion, and Anticipated ASH Data - simplywall.st

A Fresh Look at Autolus Therapeutics (AUTL) Valuation Following Earnings, Obe-cel Expansion, and Anticipated ASH Data  simplywall.st

A Fresh Look at Autolus Therapeutics (AUTL) Valuation Following Earnings, Obe-cel Expansion, and Anticipated ASH Data - simplywall.st

Click here to get full coverage on New Analyst Forecast: $AUTL Given $10 Price Target | AUTL Stock News - Quiver Quantitative

New Analyst Forecast: $AUTL Given $10 Price Target | AUTL Stock News  Quiver Quantitative

New Analyst Forecast: $AUTL Given $10 Price Target | AUTL Stock News - Quiver Quantitative

Click here to get full coverage on Biotech Autolus lines up TD Cowen, Jefferies investor events in March - Stock Titan

Biotech Autolus lines up TD Cowen, Jefferies investor events in March  Stock Titan

Biotech Autolus lines up TD Cowen, Jefferies investor events in March - Stock Titan

Click here to get full coverage on Does Autolus Therapeutics (AUTL) Pairing AUCATZYL Approvals With Revenue Guidance Redefine Its Long-Term Story? - Yahoo Finance

Does Autolus Therapeutics (AUTL) Pairing AUCATZYL Approvals With Revenue Guidance Redefine Its Long-Term Story?  Yahoo Finance

Does Autolus Therapeutics (AUTL) Pairing AUCATZYL Approvals With Revenue Guidance Redefine Its Long-Term Story? - Yahoo Finance

Click here to get full coverage on How Investors Are Reacting To Autolus Therapeutics (AUTL) Trimming Losses and Appointing a New Finance Chief - Yahoo Finance

How Investors Are Reacting To Autolus Therapeutics (AUTL) Trimming Losses and Appointing a New Finance Chief  Yahoo Finance

How Investors Are Reacting To Autolus Therapeutics (AUTL) Trimming Losses and Appointing a New Finance Chief - Yahoo Finance

Click here to get full coverage on Inside the push to automate production of a leukemia cell therapy - Stock Titan

Inside the push to automate production of a leukemia cell therapy  Stock Titan

Inside the push to automate production of a leukemia cell therapy - Stock Titan

Click here to get full coverage on Is Autolus Therapeutics PLC (AUTL) One of the Fastest-Growing Penny Stocks to Buy Now? - Yahoo Finance

Is Autolus Therapeutics PLC (AUTL) One of the Fastest-Growing Penny Stocks to Buy Now?  Yahoo Finance

Is Autolus Therapeutics PLC (AUTL) One of the Fastest-Growing Penny Stocks to Buy Now? - Yahoo Finance

Click here to get full coverage on Autolus (Nasdaq: AUTL) to Launch AUCATZYL on NHS in England and Wales After NICE Backing - Stock Titan

Autolus (Nasdaq: AUTL) to Launch AUCATZYL on NHS in England and Wales After NICE Backing  Stock Titan

Autolus (Nasdaq: AUTL) to Launch AUCATZYL on NHS in England and Wales After NICE Backing - Stock Titan

Click here to get full coverage on Autolus Therapeutics plc (NASDAQ:AUTL) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year - Yahoo Finance

Autolus Therapeutics plc (NASDAQ:AUTL) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year  Yahoo Finance

Autolus Therapeutics plc (NASDAQ:AUTL) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year - Yahoo Finance

Click here to get full coverage on Autolus (Nasdaq: AUTL) moves obe-cel into Phase 2 LUMINA lupus nephritis trial - Stock Titan

Autolus (Nasdaq: AUTL) moves obe-cel into Phase 2 LUMINA lupus nephritis trial  Stock Titan

Autolus (Nasdaq: AUTL) moves obe-cel into Phase 2 LUMINA lupus nephritis trial - Stock Titan

Click here to get full coverage on Why is Autolus Therapeutics plc (AUTL) One of the Best Stocks Under $5 With Highest Upside Potential? - Yahoo Finance

Why is Autolus Therapeutics plc (AUTL) One of the Best Stocks Under $5 With Highest Upside Potential?  Yahoo Finance

Why is Autolus Therapeutics plc (AUTL) One of the Best Stocks Under $5 With Highest Upside Potential? - Yahoo Finance

Click here to get full coverage on Autolus Therapeutics (Nasdaq: AUTL) adds ex-BioNTech strategy chief Ryan Richardson to its Board of Directors - Stock Titan

Autolus Therapeutics (Nasdaq: AUTL) adds ex-BioNTech strategy chief Ryan Richardson to its Board of Directors  Stock Titan

Autolus Therapeutics (Nasdaq: AUTL) adds ex-BioNTech strategy chief Ryan Richardson to its Board of Directors - Stock Titan

Click here to get full coverage on Needham Keeps Buy Rating on Autolus (AUTL) with a $10 Target - Yahoo Finance

Needham Keeps Buy Rating on Autolus (AUTL) with a $10 Target  Yahoo Finance

Needham Keeps Buy Rating on Autolus (AUTL) with a $10 Target - Yahoo Finance

Click here to get full coverage on Autolus Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 27, 2026 - The Manila Times

Autolus Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 27, 2026  The Manila Times

Autolus Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 27, 2026 - The Manila Times

Click here to get full coverage on Autolus (Nasdaq: AUTL) to present fireside chat at Jefferies; webcast 7:30am EST - Stock Titan

Autolus (Nasdaq: AUTL) to present fireside chat at Jefferies; webcast 7:30am EST  Stock Titan

Autolus (Nasdaq: AUTL) to present fireside chat at Jefferies; webcast 7:30am EST - Stock Titan

Click here to get full coverage on Autolus Therapeutics plc (AUTL): Analysts See 697% Upside Potential - Yahoo Finance

Autolus Therapeutics plc (AUTL): Analysts See 697% Upside Potential  Yahoo Finance

Autolus Therapeutics plc (AUTL): Analysts See 697% Upside Potential - Yahoo Finance

Click here to get full coverage on Autolus Therapeutics Presents Promising Obe-cel Data for Pediatric r/r B-ALL at ASH Annual Meeting - Quiver Quantitative

Autolus Therapeutics Presents Promising Obe-cel Data for Pediatric r/r B-ALL at ASH Annual Meeting  Quiver Quantitative

Autolus Therapeutics Presents Promising Obe-cel Data for Pediatric r/r B-ALL at ASH Annual Meeting - Quiver Quantitative

Click here to get full coverage on Autolus Therapeutics: Trading At Cash Is Not Justified With This Pipeline (NASDAQ:AUTL) - Seeking Alpha

Autolus Therapeutics: Trading At Cash Is Not Justified With This Pipeline (NASDAQ:AUTL)  Seeking Alpha

Autolus Therapeutics: Trading At Cash Is Not Justified With This Pipeline (NASDAQ:AUTL) - Seeking Alpha

Click here to get full coverage on Autolus: Good Product, But Tricky Market Dynamics (Rating Downgrade) (NASDAQ:AUTL) - Seeking Alpha

Autolus: Good Product, But Tricky Market Dynamics (Rating Downgrade) (NASDAQ:AUTL)  Seeking Alpha

Autolus: Good Product, But Tricky Market Dynamics (Rating Downgrade) (NASDAQ:AUTL) - Seeking Alpha

Click here to get full coverage on Autolus Therapeutics Reports Q3 2025 Financial Results and Highlights Progress in AUCATZYL® Launch and Clinical Development - Quiver Quantitative

Autolus Therapeutics Reports Q3 2025 Financial Results and Highlights Progress in AUCATZYL® Launch and Clinical Development  Quiver Quantitative

Autolus Therapeutics Reports Q3 2025 Financial Results and Highlights Progress in AUCATZYL® Launch and Clinical Development - Quiver Quantitative

Click here to get full coverage on Autolus Therapeutics Announces Preliminary 2025 Revenue and 2026 Outlook - TradingView

Autolus Therapeutics Announces Preliminary 2025 Revenue and 2026 Outlook  TradingView

Autolus Therapeutics Announces Preliminary 2025 Revenue and 2026 Outlook - TradingView

Click here to get full coverage on AUTL Stocks Rise: Bargain or Bubble? - timothysykes.com

AUTL Stocks Rise: Bargain or Bubble?  timothysykes.com

AUTL Stocks Rise: Bargain or Bubble? - timothysykes.com

Click here to get full coverage on The Market Doesn't Like What It Sees From Autolus Therapeutics plc's (NASDAQ:AUTL) Revenues Yet As Shares Tumble 26% - simplywall.st

The Market Doesn't Like What It Sees From Autolus Therapeutics plc's (NASDAQ:AUTL) Revenues Yet As Shares Tumble 26%  simplywall.st

The Market Doesn't Like What It Sees From Autolus Therapeutics plc's (NASDAQ:AUTL) Revenues Yet As Shares Tumble 26% - simplywall.st

Click here to get full coverage on Autolus Therapeutics Grants Stock Options to 60 Employees Under 2025 Inducement Plan - Quiver Quantitative

Autolus Therapeutics Grants Stock Options to 60 Employees Under 2025 Inducement Plan  Quiver Quantitative

Autolus Therapeutics Grants Stock Options to 60 Employees Under 2025 Inducement Plan - Quiver Quantitative

Click here to get full coverage on Autolus Therapeutics: Expanding The Reach Of Its CD19 Therapy, But Still Far From Profitable - Seeking Alpha

Autolus Therapeutics: Expanding The Reach Of Its CD19 Therapy, But Still Far From Profitable  Seeking Alpha

Autolus Therapeutics: Expanding The Reach Of Its CD19 Therapy, But Still Far From Profitable - Seeking Alpha

Click here to get full coverage on Autolus Therapeutics Signs Long-Term Lentiviral Supply Agreement - TipRanks

Autolus Therapeutics Signs Long-Term Lentiviral Supply Agreement  TipRanks

Autolus Therapeutics Signs Long-Term Lentiviral Supply Agreement - TipRanks

Click here to get full coverage on Why Is Autolus Therapeutics Stock Trading Higher On Tuesday? - Benzinga

Why Is Autolus Therapeutics Stock Trading Higher On Tuesday?  Benzinga

Why Is Autolus Therapeutics Stock Trading Higher On Tuesday? - Benzinga

Click here to get full coverage on Autolus Therapeutics Q3 2025 Earnings Call Transcript - MarketBeat

Autolus Therapeutics Q3 2025 Earnings Call Transcript  MarketBeat

Autolus Therapeutics Q3 2025 Earnings Call Transcript - MarketBeat

Click here to get full coverage on Needham raises Autolus Therapeutics stock price target on Aucatzyl launch success - Investing.com

Needham raises Autolus Therapeutics stock price target on Aucatzyl launch success  Investing.com

Needham raises Autolus Therapeutics stock price target on Aucatzyl launch success - Investing.com

Click here to get full coverage on Autolus Therapeutics plc (AUTL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Autolus Therapeutics plc (AUTL) Stock Price | Live Quotes & Charts | NASDAQ  StocksToTrade

Autolus Therapeutics plc (AUTL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Click here to get full coverage on Autolus Therapeutics Surges: What’s Next for the Stock? - StocksToTrade

Autolus Therapeutics Surges: What’s Next for the Stock?  StocksToTrade

Autolus Therapeutics Surges: What’s Next for the Stock? - StocksToTrade

Click here to get full coverage on Autolus Therapeutics PLC (AUTL) Q1 2025 Earnings Report Preview: What to Expect - Yahoo Finance

Autolus Therapeutics PLC (AUTL) Q1 2025 Earnings Report Preview: What to Expect  Yahoo Finance

Autolus Therapeutics PLC (AUTL) Q1 2025 Earnings Report Preview: What to Expect - Yahoo Finance

Click here to get full coverage on Spotlight On Silence Therapeutics And 2 Other Promising Penny Stocks - simplywall.st

Spotlight On Silence Therapeutics And 2 Other Promising Penny Stocks  simplywall.st

Spotlight On Silence Therapeutics And 2 Other Promising Penny Stocks - simplywall.st

Click here to get full coverage on Aug Patterns: Is AUTL a top pick in the sector - Market Risk Summary & Reliable Intraday Trade Plans - baoquankhu1.vn

Aug Patterns: Is AUTL a top pick in the sector - Market Risk Summary & Reliable Intraday Trade Plans  baoquankhu1.vn

Aug Patterns: Is AUTL a top pick in the sector - Market Risk Summary & Reliable Intraday Trade Plans - baoquankhu1.vn

Click here to get full coverage on H.C. Wainwright Starts Autolus Therapeutics plc (AUTL) at Buy - StreetInsider

H.C. Wainwright Starts Autolus Therapeutics plc (AUTL) at Buy  StreetInsider

H.C. Wainwright Starts Autolus Therapeutics plc (AUTL) at Buy - StreetInsider

Click here to get full coverage on Autolus Therapeutics Signs Master Service Agreement With AGC Biologics - TradingView

Autolus Therapeutics Signs Master Service Agreement With AGC Biologics  TradingView

Autolus Therapeutics Signs Master Service Agreement With AGC Biologics - TradingView

Click here to get full coverage on Ryan Richardson joins Autolus Therapeutics board of directors - Investing.com

Ryan Richardson joins Autolus Therapeutics board of directors  Investing.com

Ryan Richardson joins Autolus Therapeutics board of directors - Investing.com

Click here to get full coverage on Autolus reports positive early data from lupus treatment trial - Investing.com

Autolus reports positive early data from lupus treatment trial  Investing.com

Autolus reports positive early data from lupus treatment trial - Investing.com

Click here to get full coverage on Autolus Therapeutics stock jumps after Needham raises price target - Investing.com Nigeria

Autolus Therapeutics stock jumps after Needham raises price target  Investing.com Nigeria

Autolus Therapeutics stock jumps after Needham raises price target - Investing.com Nigeria

Click here to get full coverage on Autolus: A Buy Before Key Data Readout, Potential Expansion Into Autoimmune Market (AUTL) - Seeking Alpha

Autolus: A Buy Before Key Data Readout, Potential Expansion Into Autoimmune Market (AUTL)  Seeking Alpha

Autolus: A Buy Before Key Data Readout, Potential Expansion Into Autoimmune Market (AUTL) - Seeking Alpha

Click here to get full coverage on Industry Analysts Just Upgraded Their Autolus Therapeutics plc (NASDAQ:AUTL) Revenue Forecasts By 12% - simplywall.st

Industry Analysts Just Upgraded Their Autolus Therapeutics plc (NASDAQ:AUTL) Revenue Forecasts By 12%  simplywall.st

Industry Analysts Just Upgraded Their Autolus Therapeutics plc (NASDAQ:AUTL) Revenue Forecasts By 12% - simplywall.st

Click here to get full coverage on AUTL Stock Price, News & Analysis - Stock Titan

AUTL Stock Price, News & Analysis  Stock Titan

AUTL Stock Price, News & Analysis - Stock Titan

Click here to get full coverage on Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics - TradingView

Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics  TradingView

Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics - TradingView

Click here to get full coverage on Autolus Therapeutics sees cash runway to launch, commercialization of obe-cel - Yahoo Finance

Autolus Therapeutics sees cash runway to launch, commercialization of obe-cel  Yahoo Finance

Autolus Therapeutics sees cash runway to launch, commercialization of obe-cel - Yahoo Finance

Click here to get full coverage on Autolus Therapeutics Showcases Promising Innovations and Stock Resilience - timothysykes.com

Autolus Therapeutics Showcases Promising Innovations and Stock Resilience  timothysykes.com

Autolus Therapeutics Showcases Promising Innovations and Stock Resilience - timothysykes.com

Click here to get full coverage on Autolus Therapeutics (AUTL) Stock Analysis: Exploring a 315% Potential Upside in Biotech Innovation - directorstalkinterviews.com

Autolus Therapeutics (AUTL) Stock Analysis: Exploring a 315% Potential Upside in Biotech Innovation  directorstalkinterviews.com

Autolus Therapeutics (AUTL) Stock Analysis: Exploring a 315% Potential Upside in Biotech Innovation - directorstalkinterviews.com

Click here to get full coverage on HC Wainwright & Co. initiates coverage of Autolus Therapeutics plc - depositary receipt (AUTL) with buy recommendation - MSN

HC Wainwright & Co. initiates coverage of Autolus Therapeutics plc - depositary receipt (AUTL) with buy recommendation  MSN

HC Wainwright & Co. initiates coverage of Autolus Therapeutics plc - depositary receipt (AUTL) with buy recommendation - MSN

Click here to get full coverage on Praxis Precision Medicines To Rally More Than 213%? Here Are 8 Top Analyst Forecasts For Monday - Benzinga

Praxis Precision Medicines To Rally More Than 213%? Here Are 8 Top Analyst Forecasts For Monday  Benzinga

Praxis Precision Medicines To Rally More Than 213%? Here Are 8 Top Analyst Forecasts For Monday - Benzinga

Click here to get full coverage on Autolus Therapeutics Boosts Market Confidence with Promising Data at American Society Meeting - StocksToTrade

Autolus Therapeutics Boosts Market Confidence with Promising Data at American Society Meeting  StocksToTrade

Autolus Therapeutics Boosts Market Confidence with Promising Data at American Society Meeting - StocksToTrade

Click here to get full coverage on Needham ups Autolus target, names top pick for 2026 - Yahoo Finance

Needham ups Autolus target, names top pick for 2026  Yahoo Finance

Needham ups Autolus target, names top pick for 2026 - Yahoo Finance

Click here to get full coverage on symbol__ Stock Quote Price and Forecast - CNN

symbol__ Stock Quote Price and Forecast  CNN

symbol__ Stock Quote Price and Forecast - CNN

Click here to get full coverage on Earnings call transcript: Autolus Therapeutics Q3 2025 reports wider EPS loss - Investing.com

Earnings call transcript: Autolus Therapeutics Q3 2025 reports wider EPS loss  Investing.com

Earnings call transcript: Autolus Therapeutics Q3 2025 reports wider EPS loss - Investing.com

Click here to get full coverage on Why Gelteq Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket - Benzinga

Why Gelteq Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket  Benzinga

Why Gelteq Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket - Benzinga

Click here to get full coverage on Needham reiterates Autolus Therapeutics plc - Depositary Receipt (AUTL) buy recommendation - MSN

Needham reiterates Autolus Therapeutics plc - Depositary Receipt (AUTL) buy recommendation  MSN

Needham reiterates Autolus Therapeutics plc - Depositary Receipt (AUTL) buy recommendation - MSN

Click here to get full coverage on 13 Best Get Rich Fast Stocks to Buy Right Now - Insider Monkey

13 Best Get Rich Fast Stocks to Buy Right Now  Insider Monkey

13 Best Get Rich Fast Stocks to Buy Right Now - Insider Monkey

Click here to get full coverage on Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 42%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Autolus Therapeutics (NASDAQ:AUTL), Brand Engagement Network (NASDAQ:BNAI) - Benzinga

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 42%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Autolus Therapeutics (NASDAQ:AUTL), Brand Engagement Network (NASDAQ:BNAI)  Benzinga

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 42%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Autolus Therapeutics (NASDAQ:AUTL), Brand Engagement Network (NASDAQ:BNAI) - Benzinga

Click here to get full coverage on DigitalBridge Group, Eightco Holdings, Palisade Bio And Other Big Stocks Moving Higher On Monday - Benzinga

DigitalBridge Group, Eightco Holdings, Palisade Bio And Other Big Stocks Moving Higher On Monday  Benzinga

DigitalBridge Group, Eightco Holdings, Palisade Bio And Other Big Stocks Moving Higher On Monday - Benzinga

Click here to get full coverage on Autolus Therapeutics Gets Favorable Recommendation For Approval Of Cancer Therapy In EU: Retail Sentiment Brightens - Stocktwits

Autolus Therapeutics Gets Favorable Recommendation For Approval Of Cancer Therapy In EU: Retail Sentiment Brightens  Stocktwits

Autolus Therapeutics Gets Favorable Recommendation For Approval Of Cancer Therapy In EU: Retail Sentiment Brightens - Stocktwits

Click here to get full coverage on Why Autolus Therapeutics (AUTL) Is One of the Best Biotech Penny Stocks to Invest in Now? - Yahoo Finance

Why Autolus Therapeutics (AUTL) Is One of the Best Biotech Penny Stocks to Invest in Now?  Yahoo Finance

Why Autolus Therapeutics (AUTL) Is One of the Best Biotech Penny Stocks to Invest in Now? - Yahoo Finance

Click here to get full coverage on Autolus Therapeutics Soars as Needham Lifts Price Target on Strong Aucatzyl Sales - StockInvest.us

Autolus Therapeutics Soars as Needham Lifts Price Target on Strong Aucatzyl Sales  StockInvest.us

AUTL

Price Chart

Key Statistics

Technicals

About AUTL

Latest News

T cell therapy company Autolus schedules Mar. 27 results call - Stock Titan

Autolus Therapeutics to Announce Q4 and Full Year 2025 Financial Results on March 27, 2026 - Quiver Quantitative

Autolus Therapeutics (AUTL) Valuation Check After Revenue Guidance And AUCATZYL UK And EU Approvals - Yahoo Finance

Advanced Charts

Top Gainers

Top Losers